THE SPANISH HIV CLINICAL FORUM: INTEGRASE INHIBITORS IS COMING TO MADRID ON 8-9 JUNE 2018!
The meeting will include plenary lectures in Spanish and English and plenty of opportunity to interact with key experts in the field during Q&A and discussions!
This state-of-the-art program provides challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction and bridging the knowledge gap between experts and the HIV treating community in Spain. Additionally, the program includes parallel skills building sessions followed by a session where the medical community shares their clinical experience by presenting and discussing clinical cases.
The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts / research programs.
Furthermore, the HIV CLINICAL FORUM encourages skills building for optimal interpretation of research results, developing collaborations and initiating research projects.
Erasmus Medical Center,
Sheba Medical Center,
Hospital La Paz,
Hospital Universitari Germans Trias i Pujol, Spain
FRIDAY 8 JUNE
12:30 Registration, Reception, Coffee
14:00 Welcome, Introduction and Goals
14:10 State of the ART: Integrase Inhibitors Clinical Data
Juan Berenguer, MD – Hospital General Gregorio Marañón, Madrid
14:40 State of the ART: Integrase Inhibitors Resistance (an update)
Jonathan Schapiro, MD – Sheba Medical Center, Israel
Abstract driven presentations
15:15 Integrase inhibitors and virological failure: a cohort analysis
Montejano, Rocio. Hospital Universitario La Paz, Madrid
15:25 Análisis descriptivo de mutaciones asociadas a resistencia (MR) para
inhibidores de la integrasa (INI) del VIH en el Hospital Universitario de La
Princesa de Madrid
García-Fraile Fraile, Lucio Jesús. Hospital Universitario De La Princesa,
15:35 Coffee break
Session 2 - Changing the paradigm: Reduced drug regimens
16:00 What is the Virological support for reduced drug regimens?
Josep M. Llibre, MD, PhD - Hospital Universitari Germans Trias i Pujol, Barcelona
16:20 What is the Pharmacological support for reduced drug regimens?
Esteban Ribera, MD, PhD - Hospital Universitari Vall d'Hebron, Barcelona
16:45 What are the Clinical data for reduced drug regimens?
Babafemi O. Taiwo, MBBS - Northwestern University, USA
Abstract driven presentations
17:30 Comparative clinical experience with the two STR co-formulations with
integrase inhibitors for the treatment of HIV patients
Hernández García, Guiomar. Hospital Universitario Príncipe De Asturias,
Alcalá De Henares
17.40 Eficacia y tolerabilidad del tratamiento con Elvitegravir, Cobicistat,
Emtricitabina y Tenofovir Alafenamida (EVG/COBI/FTC/TAF) en
pacientes con infección por VIH. Análisis a 24 semanas
Bautista, Azucena. Hospital De La Princesa, Madrid
17.50 Biterapias basadas en Dolutegravir: ¿son una realidad y una necesidad
en la práctica clínica diaria?
Ferrer, Ana. Hospital Clínico Universitario, Valencia
18.00 Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-
infected patients: 48-week results of the KIRAL study
Troya, Jésus. Hospital Universitario Infanta Leonor, Madrid
18:20 Welcome reception
19:30 Networking Dinner
SATURDAY 9 JUNE
Session 3 - Integrase Inhibitors in Routine Care
09:00 Optimizing Clinical Care
José Arribas, MD - Hospital Universitario La Paz, Madrid
09:20 Optimal Clinical Care in special populations
Matilde Sánchez Conde, MD - Hospital Universitario Ramón y Cajal, Madrid
Abstract driven presentation
09:55 Interstitial pneumonia by triple viral co-infection in a CDC C2 HIV-
Bracke, Carme. Hospital Germans Trias I Pujol, Badalona
10:05 Clinical Case presentation
Antonio Antela, MD - Hospital Clínico Universitario de Santiago de Compostela, A Coruña
10:45 Coffee break
Session 4 - Novel delivery systems
11:15 Integrating novel delivery systems/novel drugs
Maria Luisa Montes, MD, PhD - Hospital Universitario La Paz, Madrid
12:00 Closing Remarks
12:10 End of Meeting
Session 1 - State of the Art Update - Integrase Inhibitors
Are you doing research on one of the topics below and have data that you would like to share and/or discuss with your colleagues? Then we encourage you to submit your abstract!
Please note that those with accepted abstract will be offered a CPG (guaranteed).
• Basic Virology
• Pharmacology and Drug interactions
• Reduced Drug Regimens
• Clinical Trials
• Informative case reports
ABSTRACT SUBMISSION IS NOW OPEN
Abstracts should contain the following four components (please bold the four section headings noted below within the text of your abstract submission):
Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. We advise you to keep a word count for the abstract body to a maximum of 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially.
Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to submitting authors before 11 May 2018. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status.
Please notify the Conference Secretariat if you have not received notification by 14 May 2018.
If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled.
Abstract Submitter’s Registration Guidelines will be sent together with the notification. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.
Accepted abstracts will be published in the Conference Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal "Reviews in Antiviral Therapy & Infectious Diseases". Please note that the Conference Secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.
Registration is free of charge for all healthcare practitioners*. A registration fee applies to other individuals.
*Healthcare practitioners are defined as professionals that provide any type of health care service to patients living with HIV. If you are not sure, please do not hesitate to contact us at firstname.lastname@example.org.
CONFERENCE PARTICIPATION GRANTS (CPG)
EXTENDED deadline: Friday 11 May 2018
Virology Education (VE), with generous support by Laboratorios ViiV Healthcare is offering Conference Participation Grants (CPGs) for the Spanish HIV Clinical Forum to HIV healthcare professionals from Spain.
What the CPG covers
Support for air/train travel of up to EUR 300
Hotel accommodation for 1 night on Friday 8 June 2018
a) All arrangements will be made by Virology Education
b) Applicants must attend the entire Conference.
c) Applicants will be responsible for all other costs associated with Conference attendance.
d) Please see the Conference website for further details about the Conference.
What is expected from you:
Recipient will be onsite at the Conference, attend all sessions and participate actively for the duration of the Conference. Recipient must sign in to each session as requested by VE.
Recipient will provide a post-meeting feedback and summary about his/her Conference experience within 1 month after the end of the Conference. The feedback questionnaire will be an online survey with the recipient providing feedback on their experience at the conference, CPG procedure and how they will implement the knowledge acquired at the meeting in their daily practice. The questionnaire will be send to each recipient by email within one week after the conclusion of the conference.
The applicant must be a Healthcare Professional.
The applicant must be willing to share his/her experience at the Conference within his network.
The applicant must be eligible to obtain a visa for travel.
The applicant must declare that she/he is able and willing to fund all other costs beyond the grant that are involved in attending the Conference, e.g. all other hotel, travel and subsistence expenses NOT covered by the CPG.
The applicant must declare to take out her/his own insurance policies (for travel, liability, illness and/or other necessary insurances in relation to her/his participation to the Conference).
Your application will include the following:
Your contact details (e.g. name and email address)
Motivation letter consisting of a written statement of up to 200 words, on
how attending the Conference will benefit you in a professional capacity
how you intend to apply the benefits that you have outlined in a practical way after the Conference
Recommendation letter(s) (optional)
A declaration that you agree with the terms & conditions for application
Your application must be received by 11 May 2018.
All applications will be acknowledged upon receipt.
All applications will be reviewed by an independent CPG Review Committee based on the following Grant Selection Criteria:
Strategy of knowledge dissemination
Recommendation by the Scientific and Organizing Committee of the meeting
Quality of the Abstract (if accepted)
Young/ Early Career Investigator
All applicants will receive notification of the application status no later than 25 May 2018.
Please submit your application through the CPG Application Portal on the Conference website.
We humbly request your support in encouraging healthcare professionals to apply by forwarding this information to your colleagues.
This educational activity is supported by an educational grant from Laboratorios ViiV Healthcare.
*The opinions of the speakers do not necessarily reflect GeSIDA's stances
We trust that the following information (in alphabetical order) will assist you in organizing your registration and stay in Spain.
The accommodation information will be coming soon.
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent by e-mail after the workshop.
Conference materials can be obtained upon registration at the registration desk at the Conference Venue starting 12.30 PM
on Friday 8 June.
The official conference language is Spanish and English.
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
The meeting will be held at Ayre Gran Hotel Colón, a 4-star designer hotel located in the center of Madrid, and very close to the Retiro Park, the Las Ventas Bull Ring and the Salamanca commercial district. (Source: http://www.ayrehoteles.com/hoteles/ayre-gran-hotel-colon/)
Ayre Gran Hotel Colón
C/ del Pez Volador, 1
T: +34 91 4009900
Free WIFI will be available in the meeting room. Access codes will be made available on the first day of the meeting.
Payment and procedure of on-line registration
Registration is free of charge for all healthcare practitioners. Your registration will be confirmed as soon as possible. If you do not receive a confirmation within three days after your registration, please contact the organizing secretariat email: email@example.com.
Photographs, audio and video recording
Photographs as well as audio and video recordings are not permitted at the official meeting sessions. Only the official medical writer, appointed by the organization, may make recordings. All presentations, will be posted on the workshop website (under Workshop Materials) as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
For any inquiries or questions, please contact Virology Education at firstname.lastname@example.org or call +31 (0)30 230 7140. You can also contact us by filling out the contact form.